ALPS aspires to establish a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. We intend to advance personalized medicine through ongoing innovation.
ALPS aims to become a leading healthcare destination, offering its expertise at fair and accessible prices. Our scope of biotechnology platform extends to creating a comprehensive “bench to bedside” ecosystem. This includes both upstream activities, such as sourcing raw materials and production, and to downstream operations that cover distribution, marketing and fill-and-finish processes.
Situated in the heart of Kuala Lumpur’s central business district, ALPS is a leader in the healthcare industry with core establishments including ALPS Medical Centre, operated by our subsidiary TMC Global Holdings Sdn. Bhd., and ALPS Wellness Centre, operated by ALPS Wellness Sdn. Bhd. We offer a comprehensive range of medical, aesthetic, and wellness services. MyGenome, another key subsidiary, operates a state-of-the-art molecular laboratory recognized with BioNexus status by the Malaysian government. This laboratory, accredited by the Malaysian Standard MS ISO 15189:2022, specializes in genetic sequencing and leverages expertise in DNA and mRNA analysis. Celestialab focuses on the cultivation, research, and development of cellular products. Both MyGenome and Celestialab are integral to our mission of advancing precision and preventive medicine to enhance individual health and well-being.
Furthermore, we collaborate with universities for research and development to develop product pipelines that align with our company’s mission. ALPS’ initiatives of creating a bench-to-bed platform with the competitive advantage and positioning set in place, allows the adoption of high technology pipelines at a low or conservative burn rate.
New Chapter for a Revitalized Humanity
ALPS has a vision to create a new chapter by revitalizing life so that humanity can enjoy a refreshed and rejuvenated new life of good health and wellness.
Building a Collaborative Healthcare Ecosystem: Advancing Accessible and Affordable Medicine
Our mission is to foster a fair healthcare ecosystem. ALPS has taken steps to cultivate an ecosystem of collaboration among clinicians, stakeholders, and researchers who share our vision. Together, we are dedicated to expanding the range of diagnostic and treatment options available while simultaneously reducing costs, ensuring that cutting-edge medicine is more accessible.
Leveraging on our network comprising professional providers, suppliers, and supporting services, ALPS aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
ALPS possesses in-house laboratories capable of performing a range of genomic and cellular research, including WGS, Whole Exome Sequencing (WES), targeted sequencing, mRNA tests. ALPS also operates a cGMP accredited cell manufacturing laboratory. WGS, known as the most comprehensive clinical-grade DNA test available, provides invaluable insights into an individual’s inherited genetic predispositions. By unraveling the entire genetic makeup, this sequencing offers a wealth of information that can shape personalized medicine and enhance treatment efficacy.
In the realm of diagnostics and therapeutics, mRNA gene expression profiling is rapidly becoming a game-changer by acting as molecular biomarkers. These biomarkers are crucial for the early, accurate prediction and diagnosis of diseases, heralding a more proactive stance in healthcare management. mRNA tests provide a window into gene expression changes as they occur, facilitating prompt medical interventions to preempt disease progression.
ALPS is committed to integrate WGS and mRNA expression profiling into routine diagnostic practices and to forge new paths in personalized medicine. Looking ahead, we aim to further enhance our service offerings by integrating the production and cultivation of autologous stem cells directly within our facilities. Additionally, we intend to establish an international research and development hub, collaborating with renowned scientists and institutions to advance cellular therapy as therapeutic entities.
The Group commenced business in 1994 when Dr. THAM Seng Kong started his private practice. Celebre Pro Medic Sdn Bhd was established soon after to provide advanced stem cell therapy products developed by a reputable Swiss laboratory that is one of the pioneers and global leader in biomedical products, with direct access to all their state-of-the-art resources and Research & Development facilities.
The key driving force behind ALPS is the founder, Dr. THAM an established member of the Malaysian Society for Stem Cell Research & Theraphy (MSCRT) and the Malaysia Association for Cell Therapy (MACT) in Malaysia. He is a veteran in the field of life sciences, with a genuine passion for the field of Cellular Therapy. Dr. THAM earned his Bachelor of Medicine from Xiamen University, Doctor of Medicine (MD) Integrated Chinese Medicine & Western Clinical Medicine (Oncology) from Guangzhou University of Chinese Medicine (GUCM) and Doctor of Medicine (MD) in Biomedical Engineering. Presently he has the privilege of treating and consulting international members of royalty, celebrities, and members of the elite. A well sought-after Educator on Best Practices, he also dedicates his time between clinical physicians and members of the public.
The ICON, East Wing Tower, Level 18-01 & 18-02, No.1, Jalan 1/68F, Off Jalan Tun Razak, 50400 Kuala Lumpur